Table 1.
Analysis of Intact Extracellular Vesicles (EVs) From Plasma of Patients With Glioma
| Biomarker | Method | Study |
|---|---|---|
| EV count, Annexin V | Cryo-electron microscopy (CM) Flow cytometry (FCM) |
Evans et al13 |
| EV count, Annexin V | FCM Electron microscopy (EM) |
Koch et al14 |
| EV count and characterization | Nanoparticle tracking analysis (NTA) | Cumba Garcia et al15 |
| EV count and characterization | NTA Confocal laser scanning microscopy (CLSM) |
Osti et al16 |
| EV count and size | NTA Transmission electron microscopy (TEM) |
Akers et al17 |
| EV size and count, CD63, CD81, CD9 | NTA TEM Imaging flow cytometry (IFCM) Correlative light electron microscopy (CLEM) |
Ricklefs et al18 |
| EGFR, EGFRvIII, PDGFR, PDPN, EphA2 and IDH1, R132H | Size and immunoaffinity Microfluidic nuclear magnetic resonance (µNMR) assay |
Shao et al19 |
| Total protein quantification | FCM TEM |
Muller et al20 |